Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01713985 · ClinicalTrials.gov registry record · NA

Feasibility Study: Evaluation of Ulthera Versus Thermage for Treating the Face and Neck

A NA study, sponsored by Ulthera.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT01713985 is a NA study that has completed, run by Ulthera. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01713985, a NA study, has completed, sponsored by Ulthera.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

Up to 20 subjects will be enrolled and randomly assigned to one of two treatment groups. Group A will receive Ultherapy™ on the right side of the face and neck and Thermage on the left side. Group B will receive Thermage on the right side of the face and neck and Ultherapy™ on the left side. Follow-up visits will occur at 90 and 180 days post-treatment. Study images will be obtained pre-treatment, immediately post-treatment, and at each follow-up visit.

Interventions

  • DEVICE Ulthera System Treatment
  • DEVICE Thermage

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2012-09
Est. Completion 2013-08
Phase NA

Sponsor

Ulthera

42 total trials

What the Registry Record Tells You About NCT01713985

The ClinicalTrials.gov registry entry for NCT01713985 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ulthera, which has 42 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Ulthera System Treatment is the first listed.

NCT01713985 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01713985 about?

NCT01713985 is a clinical study titled "Feasibility Study: Evaluation of Ulthera Versus Thermage for Treating the Face and Neck". Up to 20 subjects will be enrolled and randomly assigned to one of two treatment groups. Group A will receive Ultherapy™ on the right side of the face and neck and Thermage on the left side. Group B will receive Thermage on the right side of the face and neck and Ultherapy™ on the left side. Follow-...

What is the current status of trial NCT01713985?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2012-09. Estimated completion is 2013-08.

What interventions are being tested in trial NCT01713985?

The interventions under investigation include: Ulthera System Treatment (DEVICE), Thermage (DEVICE).

Who is sponsoring clinical trial NCT01713985?

This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.